Future Market Insights3 天
Global Warm Autoimmune Hemolytic Anemia (WAIHA) Treatment Industry to reach USD 1598 ...
The global warm autoimmune hemolytic anemia (waiha) treatment industry is worth USD 638.96 Million in the year 2023 and is ...
Too Old to Operate3 天
Transfusion and HSCT Improve CBF in SCD Compared to Hydroxyurea
Sickle cell disease (SCD) is a genetic disorder that results in the production of abnormal hemoglobin (Hb)-S, causing ...